|
1 Indications And Usage Bethkis Is Indicated For The Management Of Cystic Fibrosis Patients With Pseudomonas Aeruginosa . Safety And Efficacy Have Not Been Demonstrated In Patients Under The Age Of Six Years, Patients With Fev 1 Less Than 40% Or Greater Than 80% Predicted, Or Patients Colonized With Burkholderia Cepacia [S Ee Clinical Studies ( 14 )] . Bethkis Is An Inhaled Aminoglycoside Antibacterial Indicated For The Management Of Cystic Fibrosis Patients With Pseudomonas Aeruginosa . ( 1 ) Safety And Efficacy Have Not Been Demonstrated In Patients Under The Age Of Six Years, Patients With A Forced Expiratory Volume In One Second (Fev 1 ) Less Than 40% Or Greater Than 80% Predicted, Or Patients Colonized With Burkholderia Cepacia . ( 1 )
|